Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2005
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1226302C Ibuprofen triaazole nucleoside ester and preparation method and use thereof
11/09/2005CN1226299C Fatty alcohol glycoside compound-acanthus ilicifolius glycoside C and its application
11/09/2005CN1226042C Chinese patent drug for treating hepatitis
11/09/2005CN1226038C Technological process of preparing water soluble marine pearl powder
11/09/2005CN1225989C Health-care tea
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962911 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
11/08/2005US6962719 includes American ginseng or extract obtained by extracting with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography
11/08/2005US6962706 for use in raising immune response against Porphyromonas gingivalis, comprising suitable adjuvant, carrier or excipient and peptide of not more than 50 amino acids including P. gingivalis epitope comprising sequence RYDDFTFEAGKKYTFTMRRAGMGDGTD
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103283A1 Novel method of screening
11/03/2005WO2005103233A1 Cultured periodontal membrane cell sheet, process for producing the same and method of use thereof
11/03/2005WO2005103049A1 Imidazopyridine compound
11/03/2005WO2005103046A1 Selenophen derivatives and the use of preventing and/or treating the diseases relating to protein aging thereof
11/03/2005WO2005103013A1 Therapeutic agent for nonviral hepatitis
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102981A1 Novel compounds and medicinal use thereof
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102381A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
11/03/2005WO2005102353A1 Supportive treatment of liver disease
11/03/2005WO2005102301A2 Hydroxymethylbutyrate compositions and uses thereof
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245613 Use of gaba-b receptor positive modulators in gastro-intestinal disorders
11/03/2005US20050245609 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245597 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders
11/03/2005US20050245595 Positive modulators of nicotinic receptor agonists
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245578 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244519 Bulking agent compositions
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244389 Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies
11/03/2005CA2807787A1 Hmb compositions and uses thereof
11/03/2005CA2562812A1 Imidazopyridine compound
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2560042A1 Hmb compositions and uses thereof
11/02/2005EP1591528A2 Method and compositions for delivery and expression of interferon-alpha nucleic acids
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591129A2 Use of neurotoxic component of botulinum toxin for treating pain associated with cervical dystonia or bepharospasm
11/02/2005EP1591120A1 Receptor agonists
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590345A1 Xanthine derivatives as muscarinic receptor antagonists
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590047A1 Composition comprising lactobacilli or bifidobacteria and use thereof
11/02/2005EP1590004A2 Improved thickened beverages for dysphagia
11/02/2005EP1589995A1 Use of avian antibodies
11/02/2005EP1589989A2 Osteogenic composition
11/02/2005EP1589982A1 Packs on the base of chalk and paraffin
11/02/2005EP1507758B1 Indole derivatives and their use as ligands for cb2 receptors
11/02/2005EP1501833B1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1501525B1 Method for producing preparations rich in tocotrienol
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1472256B1 Piperidine derivatives
11/02/2005EP1392679B1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1332149B1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/02/2005EP1263503B1 Use of cyanoquinolines for treating or inhibiting colonic polyps
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
11/02/2005EP1212039B1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1002092B1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692113A Polysubstituted imidazopyridines as gastric secretion inhibitors
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1258